Choroidal Neovascularization Market Report

Global and Region Choroidal Neovascularization Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：233
  • REPORT CODE：GMM970926
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.

    The report details the trend, potential and market size of Choroidal Neovascularization market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Choroidal Neovascularizationmarket, defines the market attractiveness level of Choroidal Neovascularization market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Choroidal Neovascularization industry, describes the types of Choroidal Neovascularization market, the applications of major players and the market size, and deeply analyzes the current situation of the global Choroidal Neovascularization market and the development prospects and opportunities of Choroidal Neovascularization industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Choroidal Neovascularization market in Chapter 13.

    By Player:

    • Regeneron Pharmaceuticals Inc

    • QLT Inc

    • F Hoffmann-La Roche Ltd

    • Promedior Inc

    • Sanwa Kagaku Kenkyusho Co Ltd

    • Pfizer Inc

    • Bayer AG

    • Valeant Pharmaceuticals International Inc

    • Novartis AG

    • Gilead Sciences Inc

    By Type:

    • Intravenous

    • Intravitreal

    By End-User:

    • Extreme Myopia

    • Malignant Myopic Degeneration

    • Age-related Developments

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Choroidal Neovascularization Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Choroidal Neovascularization Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Choroidal Neovascularization Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Choroidal Neovascularization Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Choroidal Neovascularization Market Analysis and Outlook to 2022

    • 7.1 Global Choroidal Neovascularization Consumption (2017-2022)

    • 7.2 United States Choroidal Neovascularization Consumption (2017-2022)

    • 7.3 Europe Choroidal Neovascularization Consumption (2017-2022)

    • 7.4 China Choroidal Neovascularization Consumption (2017-2022)

    • 7.5 Japan Choroidal Neovascularization Consumption (2017-2022)

    • 7.6 India Choroidal Neovascularization Consumption (2017-2022)

    • 7.7 South Korea Choroidal Neovascularization Consumption (2017-2022)

    8 Region and Country-wise Choroidal Neovascularization Market Analysis and Outlook to 2028

    • 8.1 Global Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 8.2 United States Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 8.3 Europe Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 8.4 China Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 8.5 Japan Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 8.6 India Choroidal Neovascularization Consumption Forecast (2022-2028)

    • 8.7 South Korea Choroidal Neovascularization Consumption Forecast (2022-2028)

    9 Global Choroidal Neovascularization Market Outlook by Types and Applications to 2022

    • 9.1 Global Choroidal Neovascularization Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Intravenous Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Intravitreal Consumption and Growth Rate (2017-2022)

    • 9.2 Global Choroidal Neovascularization Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Extreme Myopia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Malignant Myopic Degeneration Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Age-related Developments Consumption and Growth Rate (2017-2022)

    10 Global Choroidal Neovascularization Market Outlook by Types and Applications to 2028

    • 10.1 Global Choroidal Neovascularization Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Intravitreal Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Choroidal Neovascularization Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Extreme Myopia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Malignant Myopic Degeneration Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Age-related Developments Consumption Forecast and Growth Rate (2022-2028)

    11 Global Choroidal Neovascularization Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Choroidal Neovascularization Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Choroidal Neovascularization Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Choroidal Neovascularization Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Choroidal Neovascularization Market Competitive Analysis

    • 14.1 Regeneron Pharmaceuticals Inc

      • 14.1.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.1.2 Regeneron Pharmaceuticals Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Regeneron Pharmaceuticals Inc Choroidal Neovascularization Product and Service

    • 14.2 QLT Inc

      • 14.2.1 QLT Inc Company Details

      • 14.2.2 QLT Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 QLT Inc Choroidal Neovascularization Product and Service

    • 14.3 F Hoffmann-La Roche Ltd

      • 14.3.1 F Hoffmann-La Roche Ltd Company Details

      • 14.3.2 F Hoffmann-La Roche Ltd Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 F Hoffmann-La Roche Ltd Choroidal Neovascularization Product and Service

    • 14.4 Promedior Inc

      • 14.4.1 Promedior Inc Company Details

      • 14.4.2 Promedior Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Promedior Inc Choroidal Neovascularization Product and Service

    • 14.5 Sanwa Kagaku Kenkyusho Co Ltd

      • 14.5.1 Sanwa Kagaku Kenkyusho Co Ltd Company Details

      • 14.5.2 Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Product and Service

    • 14.6 Pfizer Inc

      • 14.6.1 Pfizer Inc Company Details

      • 14.6.2 Pfizer Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Inc Choroidal Neovascularization Product and Service

    • 14.7 Bayer AG

      • 14.7.1 Bayer AG Company Details

      • 14.7.2 Bayer AG Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer AG Choroidal Neovascularization Product and Service

    • 14.8 Valeant Pharmaceuticals International Inc

      • 14.8.1 Valeant Pharmaceuticals International Inc Company Details

      • 14.8.2 Valeant Pharmaceuticals International Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Valeant Pharmaceuticals International Inc Choroidal Neovascularization Product and Service

    • 14.9 Novartis AG

      • 14.9.1 Novartis AG Company Details

      • 14.9.2 Novartis AG Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis AG Choroidal Neovascularization Product and Service

    • 14.10 Gilead Sciences Inc

      • 14.10.1 Gilead Sciences Inc Company Details

      • 14.10.2 Gilead Sciences Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Gilead Sciences Inc Choroidal Neovascularization Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Choroidal Neovascularization

    • Figure Choroidal Neovascularization Picture

    • Table Global Choroidal Neovascularization Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Choroidal Neovascularization Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Choroidal Neovascularization Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Choroidal Neovascularization Consumption by Country (2017-2022)

    • Figure United States Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Table Europe Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure China Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Japan Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure India Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure South Korea Choroidal Neovascularization Consumption and Growth Rate (2017-2022)

    • Figure Global Choroidal Neovascularization Consumption Forecast by Country (2022-2028)

    • Figure United States Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Choroidal Neovascularization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravenous Consumption and Growth Rate (2017-2022)

    • Figure Global Intravitreal Consumption and Growth Rate (2017-2022)

    • Figure Global Extreme Myopia Consumption and Growth Rate (2017-2022)

    • Figure Global Malignant Myopic Degeneration Consumption and Growth Rate (2017-2022)

    • Figure Global Age-related Developments Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravitreal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Extreme Myopia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Malignant Myopic Degeneration Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Age-related Developments Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Choroidal Neovascularization Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Choroidal Neovascularization Export by Region (Top 5 Countries) (2017-2028)

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Choroidal Neovascularization Product and Service

    • Table QLT Inc (Foundation Year, Company Profile and etc.)

    • Table QLT Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table QLT Inc Choroidal Neovascularization Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Choroidal Neovascularization Product and Service

    • Table Promedior Inc (Foundation Year, Company Profile and etc.)

    • Table Promedior Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Promedior Inc Choroidal Neovascularization Product and Service

    • Table Sanwa Kagaku Kenkyusho Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanwa Kagaku Kenkyusho Co Ltd Choroidal Neovascularization Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Choroidal Neovascularization Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Choroidal Neovascularization Product and Service

    • Table Valeant Pharmaceuticals International Inc (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals International Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals International Inc Choroidal Neovascularization Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Choroidal Neovascularization Product and Service

    • Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Inc Choroidal Neovascularization Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Inc Choroidal Neovascularization Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US